Login

$STLN SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4/A: Chernett Jorey, 10% owner

Acquired 1,391 Call Option (STLN 19FEB27 $4C) (Open Market Purchase) ($1.11K)

13 Nov 2026 25-NSE
12 Nov 2026 8-K/A: Regulation FD Disclosure

Some of the information in this presentation is not historical in nature and may constitute forward - looking statements, which ar e made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The...

12 Nov 2026 Form 4: Chernett Jorey, 10% owner

Acquired 1,391 Call Option (STLN 19FEB27 $4C) (Open Market Purchase) ($1.11K)

12 Nov 2026 8-K: Regulation FD Disclosure

Some of the information in this presentation is not historical in nature and may constitute forward - looking statements, which ar e made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The...

10 Nov 2026 Form 4: Chernett Jorey, 10% owner

Sold 2,851,061 shares ($11.4M) · Acquired 10,000 Call Option (STLN 20NOV26 $4C) (Open Market Purchase) ($750) · Acquired 5,000 Call Option (STLN 19FEB27 $4C) (Open Market Purchase) ($2K) · 3 more

06 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

CERRITOS, Calif., November 5, 2026 -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended...

02 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On September 1, 2026, Brad Hively notified Starling Oncology, Inc. (the “Company”) of his decision to not stand for re-election to the Board of the Directors of the Company (the “Board”) at its 2027 annual meeting of stockholders (the “A...

24 Aug 2026 Form 4: Hively Brad, Director

Sold 298,853 shares ($1.95M)

21 Aug 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

STARLING ONCOLOGY MANAGEMENT, LIMITED LIABILITY COMPANY f/k/a TOI MANAGEMENT, LLC

21 Aug 2026 144
17 Aug 2026 Form 4: Chernett Jorey, 10% owner

Disposed of 100 Call Option (STLN 19FEB27 $9C) (Open Market Sale) ($624) · Bought 12,000 shares ($78.5K)

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

CERRITOS, Calif., August 6, 2026 -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended J...

03 Aug 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure

Company to begin trading on Nasdaq under new ticker symbol “STLN,” replacing “TOI”

29 Jul 2026 Form 4: Kaushal Mohit, Director

Received 33,133 shares as a grant or award

29 Jul 2026 Form 4: McGeorge Anne, Director

Received 41,165 shares as a grant or award

29 Jul 2026 Form 4: Pacala Mark L, Director

Received 30,120 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support